Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Amine Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102372642A details a safe, scalable route for (1S)-4,5-dimethoxy-1-[(methylamino)methyl]benzocyclobutane, replacing hazardous LiAlH4 with mild borohydride reduction for cost-effective manufacturing.
Novel Pd-catalyzed synthesis offers high enantioselectivity. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Solve chiral synthesis challenges with this one-pot two-step method. Achieve 95% ee, 80-89% yield, and simplified production for pharmaceutical intermediates.
Discover a metal-free, high-yield method for chiral 1,3-diamine with >97:3 dr. Reduce costs and supply chain risks in pharmaceutical synthesis.